Conv. Plasma
Nigella Sativa

All zinc studies
Meta analysis
study COVID-19 treatment researchZincZinc (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 25% Improvement Relative Risk Zinc for COVID-19  Kyagambiddwa et al.  LATE TREATMENT Is late treatment with zinc beneficial for COVID-19? Retrospective 246 patients in Uganda (May 2020 - August 2022) Lower mortality with zinc (not stat. sig., p=0.28) Kyagambiddwa et al., Infection and Dru.., May 2023 Favors zinc Favors control

Thirty-Day Outcomes of Young and Middle-Aged Adults Admitted with Severe COVID-19 in Uganda: A Retrospective Cohort Study

Kyagambiddwa et al., Infection and Drug Resistance, doi:10.2147/idr.s405256
May 2023  
  Source   PDF   All   Meta
Zinc for COVID-19
2nd treatment shown to reduce risk in July 2020
*, now known with p = 0.0000013 from 44 studies, recognized in 11 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,200+ studies for 70+ treatments.
Retrospective 246 severe COVID-19 patients in Uganda, showing lower mortality with zinc treatment in unadjusted results, without statistical significance.
Although the 25% lower mortality is not statistically significant, it is consistent with the significant 29% lower mortality [10‑44%] from meta analysis of the 20 mortality results to date.
This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
Study covers zinc and vitamin C.
risk of death, 25.4% lower, RR 0.75, p = 0.28, treatment 20 of 89 (22.5%), control 22 of 73 (30.1%), NNT 13.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Kyagambiddwa et al., 11 May 2023, retrospective, Uganda, peer-reviewed, mean age 39.0, 15 authors, study period May 2020 - August 2022. Contact:,
This PaperZincAll
Thirty-Day Outcomes of Young and Middle-Aged Adults Admitted with Severe COVID-19 in Uganda: A Retrospective Cohort Study
Tonny Kyagambiddwa, Timothy Mwanje Kintu, Emmanuel Miiro, Franchesca Nabalamba, Gloria Suubi Asiimwe, Anne Marion Namutebi, Fardous C Abeya, Boniface A Lumori, Isaac Ijuka, Rose K Muhindo, Andrew Mutekanga, Richard Musinguzi, Francis Natuhwera, Joseph Ngonzi, Edwin Nuwagira
Infection and Drug Resistance, doi:10.2147/idr.s405256
Background: There is scarcity of data regarding young and middle-aged adults hospitalized with severe Corona Virus Disease 2019 (COVID-19) in Africa. In this study, we describe the clinical characteristics and 30-day survival among adults aged 18 to 49 years admitted with severe COVID-19 in Uganda. Methods: We reviewed treatment records of patients admitted with severe COVID-19 across five COVID-19 treatment units (CTU) in Uganda. We included individuals aged 18 to 49 years, who had a positive test or met the clinical criteria for COVID-19. We defined severe COVID-19 as having an oxygen saturation <94%, lung infiltrates >50% on imaging and presence of a co-morbidity that required admission in the CTU. Our main outcome was the 30-day survival from the time of admission. We used a Cox proportional hazards model to determine the factors associated with 30-day survival at a 5% level of significance. Results: Of the 246 patient files reviewed, 50.8% (n = 125) were male, the mean ± (standard deviation) age was 39 ± 8 years, majority presented with cough, 85.8% (n = 211) and median C-reactive protein (interquartile range) was 48 (47.5, 178.8) mg/L. The 30-day mortality was 23.9% (59/246). At admission, anemia (hazard ratio (HR): 3.00, 95% confidence interval (CI), 1.32-6.82; p = 0.009) and altered mental state (GCS <15) (HR: 6.89, 95% CI: 1.48-32.08, p = 0.014) were significant predictors of 30-day mortality. Conclusion: There was a high 30-day mortality among young and middle-aged adults with severe COVID-19 in Uganda. Early recognition and targeted management of anemia and altered consciousness are needed to improve clinical outcomes.
Abbreviations Ethics Approval and Informed Consent The study was approved by the Research Ethics Committee of Mbarara University of Science and Technology under reference number MUST-2022-435. The ethics committee waived the requirement for consent. Permission for access to medical records was granted by the necessary boards at respective hospitals. Study codes were used to ensure the anonymity of participants' data. Data generated from the study shall be used for research purposes only and shall be private and confidential at all times. All principles of data transfer and principles of protection of human research participants outlined in the Declaration of Helsinki were observed. Disclosure The authors declare that they have no competing interests.
Adebisi, Rabe, Lucero-Prisno, De, COVID-19 surveillance systems in 13 African countries, Health Promot Perspect, doi:10.34172/hpp.2021.49
Anjorin, Abioye, Asowata, Comorbidities and the COVID-19 pandemic dynamics in Africa, Trop Med Int Health TM IH, doi:10.1111/tmi.13504
Apiyo, Olum, Kabuye, Clinical characteristics and outcomes of patients hospitalized with COVID-19 at case hospital, Uganda, Interdiscip Perspect Infect Dis, doi:10.1155/2022/5477790
Assal, Hm, Magdy, Predictors of severity and mortality in COVID-19 patients, Egypt J Bronchol, doi:10.1186/s43168-022-00122-0
Baguma, Okot, Alema, Factors associated with mortality among the COVID-19 patients treated at Gulu Regional referral hospital: a retrospective study, Front Public Health, doi:10.3389/fpubh.2022.841906
Bergamaschi, Borrelli De Andreis, Aronico, Anemia in patients with Covid-19: pathogenesis and clinical significance, Clin Exp Med, doi:10.1007/s10238-020-00679-4
Bongomin, Fleischer, Olum, High mortality during the second wave of the coronavirus disease 2019 (COVID-19) pandemic in Uganda: experience from a National Referral COVID-19 treatment unit, Open Forum Infect Dis, doi:10.1093/ofid/ofab530
Chen, Hoiland, Stukas, Wellington, Sekhon, Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome, Eur Respir J, doi:10.1183/13993003.03006-2020
Chinnaswamy, Understanding the devastating second wave of COVID -19 pandemic in India, Am J Hum Biol, doi:10.1002/ajhb.23671
Core, R: a language and environment for statistical computing
Cunningham, Vaduganathan, Claggett, Clinical outcomes in young US adults hospitalized with COVID-19, JAMA Intern Med, doi:10.1001/jamainternmed.2020.5313
Dadras, Seyedalinaghi, Karimi, COVID-19 mortality and its predictors in the elderly: a systematic review, Health Sci Rep, doi:10.1002/hsr2.657
English, Cn, Uganda lacks medical oxygen as hospitals overwhelmed by COVID-19, Xinhua
Gupta, Garg, Sapra, Infection and Drug Resistance Dovepress
Herrera-Esposito, De, Campos, Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies, BMC Infect Dis, doi:10.1186/s12879-022-07262-0
Hu, Huang, Yin, The cytokine storm and COVID-19, Infection and Drug Resistance, doi:10.1002/jmv.26232
Jha, Tak, Gupta, Relationship of anemia with COVID-19 deaths: a retrospective cross-sectional study, J Anaesthesiol Clin Pharmacol, doi:10.4103/joacp.joacp_63_22
Kirenga, Muttamba, Kayongo, Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda, BMJ Open Respir Res, doi:10.1136/bmjresp-2020-000646
Migisha, Kwesiga, Mirembe, Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches -march, Glob Health, doi:10.1186/s12992-020-00643-7
Mvb| Nw| Cn|, Obesity studies highlight severe COVID outcomes, even in young adults, CIDRAP
Mwananyanda, Gill, Macleod, Covid-19 deaths in Africa: prospective systematic postmortem surveillance study, BMJ, doi:10.1136/bmj.n334
News-Medical, Individuals under 65 years may be the predominant drivers of COVID-19 in West Africa
Oh, Skendelas, Macdonald, On-admission anemia predicts mortality in COVID-19 patients: a single center, retrospective cohort study, Am J Emerg Med, doi:10.1016/j.ajem.2021.03.083
Perazzo, Cardoso, Ribeiro, In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: a prospective multicenter study from Brazil, Lancet Reg Health Am, doi:10.1016/j.lana.2022.100244
Salyer, Maeda, Sembuche, The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study, Lancet, doi:10.1016/S0140-6736(21)00632-2
Sandoval, Nguyen, Vahidy, Graviss, Risk factors for severity of COVID-19 in hospital patients age 18-29 years, PLoS One, doi:10.1371/journal.pone.0255544
Snyman, Sanders, Ndung, COVID-19 in Africa: preexisting immunity and HIV, AIDS, doi:10.1097/QAD.0000000000003079
Springerlink, Altered mental status in COVID-19, doi:10.1007/s00415-021-10623-5
Springerlink, Disorders of consciousness in hospitalized patients with covid-19: the role of the systemic inflammatory response syndrome, doi:10.1007/s12028-021-01256-7
Starke, Reissig, Petereit-Haack, Schmauder, Nienhaus et al., The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis, BMJ Glob Health, doi:10.1136/bmjgh-2021-006434
Statsenko, Zahmi, Habuza, Impact of age and sex on COVID-19 severity assessed from radiologic and clinical findings, Front Cell Infect Microbiol, doi:10.3389/fcimb.2021.777070
Tabernero, Ruiz, España, COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences, Infection, doi:10.1007/s15010-021-01684-9
Tao, Xu, Chen, Anemia is associated with severe illness in COVID-19: a retrospective cohort study, J Med Virol, doi:10.1002/jmv.26444
Team, Uganda, one ICU Bed for 188,000 Ugandans. The Monitor; 2021
Van Son, Oussaada, Şekercan, Overweight and obesity are associated with acute kidney injury and acute respiratory distress syndrome, but not with increased mortality in hospitalized COVID-19 patients: a retrospective cohort study, Front Endocrinol, doi:10.3389/fendo.2021.747732
Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA, doi:10.1001/jama.2020.2648
Xiong, Lu, Zhang, Association of consciousness impairment and mortality in people with COVID-19, Acta Neurol Scand, doi:10.1111/ane.13471
Zhang, Wu, He, Age-related risk factors and complications of patients with COVID-19: a population-based retrospective study, Front Med, doi:10.3389/fmed.2021.757459
{ 'DOI': '10.2147/idr.s405256', 'ISSN': ['1178-6973'], 'URL': '', 'author': [ { 'ORCID': '', 'affiliation': [], 'authenticated-orcid': True, 'family': 'Kyagambiddwa', 'given': 'Tonny', 'sequence': 'first'}, { 'ORCID': '', 'affiliation': [], 'authenticated-orcid': True, 'family': 'Kintu', 'given': 'Timothy Mwanje', 'sequence': 'additional'}, { 'ORCID': '', 'affiliation': [], 'authenticated-orcid': True, 'family': 'Miiro', 'given': 'Emmanuel', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Nabalamba', 'given': 'Franchesca', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Asiimwe', 'given': 'Gloria Suubi', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Namutebi', 'given': 'Anne Marion', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Abeya', 'given': 'Fardous C', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Lumori', 'given': 'Boniface A', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Ijuka', 'given': 'Isaac', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Muhindo', 'given': 'Rose K', 'sequence': 'additional'}, { 'ORCID': '', 'affiliation': [], 'authenticated-orcid': True, 'family': 'Mutekanga', 'given': 'Andrew', 'sequence': 'additional'}, { 'ORCID': '', 'affiliation': [], 'authenticated-orcid': True, 'family': 'Musinguzi', 'given': 'Richard', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Natuhwera', 'given': 'Francis', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Ngonzi', 'given': 'Joseph', 'sequence': 'additional'}, { 'ORCID': '', 'affiliation': [], 'authenticated-orcid': True, 'family': 'Nuwagira', 'given': 'Edwin', 'sequence': 'additional'}], 'container-title': 'Infection and Drug Resistance', 'container-title-short': 'IDR', 'content-domain': {'crossmark-restriction': False, 'domain': []}, 'created': {'date-parts': [[2023, 5, 10]], 'date-time': '2023-05-10T13:00:28Z', 'timestamp': 1683723628000}, 'deposited': { 'date-parts': [[2023, 5, 10]], 'date-time': '2023-05-10T13:00:42Z', 'timestamp': 1683723642000}, 'indexed': {'date-parts': [[2023, 5, 11]], 'date-time': '2023-05-11T04:36:51Z', 'timestamp': 1683779811745}, 'is-referenced-by-count': 0, 'issued': {'date-parts': [[2023, 5]]}, 'language': 'en', 'license': [ { 'URL': '', 'content-version': 'unspecified', 'delay-in-days': 0, 'start': { 'date-parts': [[2023, 5, 1]], 'date-time': '2023-05-01T00:00:00Z', 'timestamp': 1682899200000}}], 'link': [ { 'URL': '', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': '', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'member': '301', 'original-title': [], 'page': '2923-2932', 'prefix': '10.2147', 'published': {'date-parts': [[2023, 5]]}, 'published-online': {'date-parts': [[2023, 5]]}, 'publisher': 'Informa UK Limited', 'reference': [ { 'key': 'ref1', 'unstructured': 'World Health Organization. Global Tuberculosis Report 2022. World Health ' 'Organization; 2022. Available from: ' ' Accessed November 11, ' '2022.'}, { 'key': 'ref2', 'unstructured': 'World Health Organization. WHO Coronavirus (COVID-19) Dashboard. ' 'Available from: Accessed August 20, 2022.'}, { 'key': 'ref3', 'unstructured': 'Worldometer. Population of Africa (2022). Available from: ' ' ' 'Accessed November 11, 2022.'}, { 'key': 'ref4', 'unstructured': 'World Health Organization. The future of WHO Covid-19 response ' 'operations in Africa in 2022. World Health Organization | Regional ' 'Office for Africa. Available from: ' ' ' 'Accessed November 11, 2022.'}, { 'DOI': '10.34172/hpp.2021.49', 'author': 'Adebisi', 'doi-asserted-by': 'publisher', 'first-page': '382', 'journal-title': 'Health Promot Perspect', 'key': 'ref5', 'volume': '11', 'year': '2021'}, { 'DOI': '10.1097/QAD.0000000000003079', 'author': 'Snyman', 'doi-asserted-by': 'publisher', 'first-page': '2391', 'journal-title': 'AIDS', 'key': 'ref6', 'volume': '35', 'year': '2021'}, { 'DOI': '10.1016/S0140-6736(21)00441-4', 'doi-asserted-by': 'crossref', 'key': 'ref7', 'unstructured': 'African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators. ' 'Patient care and clinical outcomes for patients with COVID-19 infection ' 'admitted to African high-care or intensive care units (ACCCOS): a ' 'multicentre, prospective, observational cohort study. Lancet Lond Engl. ' '2021;397(10288):1885–1894. doi:10.1016/S0140-6736(21)00441-4'}, { 'DOI': '10.1016/S0140-6736(21)00632-2', 'author': 'Salyer', 'doi-asserted-by': 'publisher', 'first-page': '1265', 'journal-title': 'Lancet', 'key': 'ref8', 'volume': '397', 'year': '2021'}, { 'DOI': '10.1111/tmi.13504', 'author': 'Anjorin', 'doi-asserted-by': 'publisher', 'first-page': '2', 'journal-title': 'Trop Med Int Health TM IH', 'key': 'ref9', 'volume': '26', 'year': '2021'}, { 'DOI': '10.1016/j.lana.2022.100244', 'author': 'Perazzo', 'doi-asserted-by': 'publisher', 'first-page': '100244', 'journal-title': 'Lancet Reg Health Am', 'key': 'ref10', 'volume': '11', 'year': '2022'}, { 'key': 'ref11', 'unstructured': 'Young People’s Potential, the Key to Africa’s Sustainable Development. ' 'Office of the high representative for the least developed Countries, ' 'landlocked developing Countries and Small Island Developing States. ' 'Available from: ' ' ' 'Accessed November 11, 2022.'}, { 'DOI': '10.1001/jama.2020.2648', 'author': 'Wu', 'doi-asserted-by': 'publisher', 'first-page': '1239', 'journal-title': 'JAMA', 'key': 'ref12', 'volume': '323', 'year': '2020'}, { 'DOI': '10.3389/fmed.2021.757459', 'author': 'Zhang', 'doi-asserted-by': 'publisher', 'journal-title': 'Front Med', 'key': 'ref13', 'volume': '8', 'year': '2022'}, { 'DOI': '10.3389/fcimb.2021.777070', 'author': 'Statsenko', 'doi-asserted-by': 'publisher', 'journal-title': 'Front Cell Infect Microbiol', 'key': 'ref14', 'volume': '11', 'year': '2022'}, { 'DOI': '10.1136/bmjgh-2021-006434', 'author': 'Starke', 'doi-asserted-by': 'publisher', 'first-page': 'e006434', 'journal-title': 'BMJ Glob Health', 'key': 'ref15', 'volume': '6', 'year': '2021'}, { 'DOI': '10.1136/bmjresp-2020-000646', 'author': 'Kirenga', 'doi-asserted-by': 'publisher', 'first-page': 'e000646', 'journal-title': 'BMJ Open Respir Res', 'key': 'ref16', 'volume': '7', 'year': '2020'}, { 'DOI': '10.1155/2022/5477790', 'author': 'Apiyo', 'doi-asserted-by': 'publisher', 'first-page': 'e5477790', 'journal-title': 'Interdiscip Perspect Infect Dis', 'key': 'ref17', 'volume': '2022', 'year': '2022'}, { 'DOI': '10.3389/fpubh.2022.841906', 'author': 'Baguma', 'doi-asserted-by': 'publisher', 'journal-title': 'Front Public Health', 'key': 'ref18', 'volume': '10', 'year': '2022'}, { 'DOI': '10.1093/ofid/ofab530', 'author': 'Bongomin', 'doi-asserted-by': 'publisher', 'first-page': '11', 'journal-title': 'Open Forum Infect Dis', 'key': 'ref19', 'volume': '8', 'year': '2021'}, { 'DOI': '10.1186/s12879-022-07262-0', 'author': 'Herrera-Esposito', 'doi-asserted-by': 'publisher', 'first-page': '311', 'journal-title': 'BMC Infect Dis', 'key': 'ref20', 'volume': '22', 'year': '2022'}, { 'DOI': '10.1007/s15010-021-01684-9', 'author': 'Tabernero', 'doi-asserted-by': 'publisher', 'first-page': '179', 'journal-title': 'Infection', 'key': 'ref21', 'volume': '50', 'year': '2022'}, { 'key': 'ref22', 'unstructured': 'In young adults with COVID-19, obesity is associated with adverse ' 'outcomes. Available from: ' 'Accessed March 24, 2023.'}, { 'key': 'ref23', 'unstructured': 'Why COVID-19 is more deadly in people with obesity—even if they’re ' 'young. Available from: ' ' ' 'Accessed August 21, 2022.'}, { 'key': 'ref24', 'unstructured': 'Apr 29 MVB| NW| CN|, 2021. Obesity studies highlight severe COVID ' 'outcomes, even in young adults. CIDRAP. Available from: ' ' ' 'Accessed August 21, 2022.'}, { 'DOI': '10.1001/jamainternmed.2020.5313', 'author': 'Cunningham', 'doi-asserted-by': 'publisher', 'first-page': '379', 'journal-title': 'JAMA Intern Med', 'key': 'ref25', 'volume': '181', 'year': '2021'}, { 'DOI': '10.3389/fendo.2021.747732', 'author': 'van Son', 'doi-asserted-by': 'publisher', 'journal-title': 'Front Endocrinol', 'key': 'ref26', 'volume': '12', 'year': '2021'}, { 'DOI': '10.1371/journal.pone.0255544', 'author': 'Sandoval', 'doi-asserted-by': 'publisher', 'first-page': 'e0255544', 'journal-title': 'PLoS One', 'key': 'ref27', 'volume': '16', 'year': '2021'}, { 'DOI': '10.1136/bmj.n334', 'author': 'Mwananyanda', 'doi-asserted-by': 'publisher', 'first-page': 'n334', 'journal-title': 'BMJ', 'key': 'ref28', 'volume': '372', 'year': '2021'}, { 'key': 'ref29', 'unstructured': ' Individuals under 65 years may be the predominant ' 'drivers of COVID-19 in West Africa; 2022. Available from: ' ' ' 'Accessed August 24, 2022.'}, { 'key': 'ref30', 'unstructured': 'R Core Team. R: a language and environment for statistical computing. R ' 'Foundation for Statistical Computing, Vienna, Austria; 2021. Available ' 'from: Accessed October 28, 2022.'}, { 'key': 'ref31', 'unstructured': 'Institute for Health Metrics and Evaluation. COVID-19 results briefing ' 'Uganda December 15 ; 2022. Available from: ' ' ' 'Accessed January 1, 2023.'}, { 'DOI': '10.1186/s12992-020-00643-7', 'author': 'Migisha', 'doi-asserted-by': 'publisher', 'first-page': '114', 'journal-title': 'Glob Health', 'key': 'ref32', 'volume': '16', 'year': '2020'}, { 'key': 'ref33', 'unstructured': 'World Health Organization. COVID-19 deaths in African region to fall by ' 'nearly 94% in 2022: WHO analysis. Regional Office for Africa. Available ' 'from: ' ' ' 'Accessed November 1, 2022.'}, { 'key': 'ref34', 'unstructured': ' Uganda lacks medical oxygen as hospitals overwhelmed by ' 'COVID-19. Xinhua. Available from: ' ' ' 'Accessed November 15, 2022.'}, { 'key': 'ref35', 'unstructured': 'Team M. Uganda: one ICU Bed for 188,000 Ugandans. The Monitor; 2021. ' 'Available from: ' 'Accessed November 15, 2022.'}, { 'DOI': '10.1002/ajhb.23671', 'author': 'Chinnaswamy', 'doi-asserted-by': 'publisher', 'journal-title': 'Am J Hum Biol', 'key': 'ref36', 'volume': '33', 'year': '2021'}, { 'DOI': '10.1002/hsr2.657', 'author': 'Dadras', 'doi-asserted-by': 'publisher', 'first-page': 'e657', 'journal-title': 'Health Sci Rep', 'key': 'ref37', 'volume': '5', 'year': '2022'}, { 'DOI': '10.1186/s43168-022-00122-0', 'author': 'Assal', 'doi-asserted-by': 'publisher', 'first-page': '1', 'journal-title': 'Egypt J Bronchol', 'key': 'ref38', 'volume': '16', 'year': '2022'}, { 'key': 'ref39', 'unstructured': 'Predictors of mortality among hospitalized COVID-19 patients at a ' 'tertiary care hospital in Ethiopia. Available from: ' ' Accessed November 18, 2022.'}, { 'key': 'ref40', 'unstructured': 'Prognostic role of anemia in COVID-19 patients: a meta-analysis. ' 'Available from: Accessed ' 'November 1, 2022.'}, { 'DOI': '10.1183/13993003.03006-2020', 'author': 'Chen', 'doi-asserted-by': 'publisher', 'first-page': '2003006', 'journal-title': 'Eur Respir J', 'key': 'ref41', 'volume': '56', 'year': '2020'}, { 'DOI': '10.1002/jmv.26232', 'author': 'Hu', 'doi-asserted-by': 'publisher', 'first-page': '250', 'journal-title': 'J Med Virol', 'key': 'ref42', 'volume': '93', 'year': '2021'}, { 'DOI': '10.1007/s10238-020-00679-4', 'author': 'Bergamaschi', 'doi-asserted-by': 'publisher', 'first-page': '239', 'journal-title': 'Clin Exp Med', 'key': 'ref43', 'volume': '21', 'year': '2021'}, { 'DOI': '10.1002/jmv.26444', 'author': 'Tao', 'doi-asserted-by': 'publisher', 'first-page': '1478', 'journal-title': 'J Med Virol', 'key': 'ref44', 'volume': '93', 'year': '2021'}, { 'DOI': '10.1016/j.ajem.2021.03.083', 'author': 'Oh', 'doi-asserted-by': 'publisher', 'first-page': '140', 'journal-title': 'Am J Emerg Med', 'key': 'ref45', 'volume': '48', 'year': '2021'}, { 'key': 'ref46', 'unstructured': 'Mild anemia as a single independent predictor of mortality in patients ' 'with COVID‐19 – Tremblay. eJHaem - Wiley Online Library; 2021. Available ' 'from: Accessed ' 'November 1, 2022.'}, { 'DOI': '10.4103/joacp.joacp_63_22', 'author': 'Jha', 'doi-asserted-by': 'publisher', 'first-page': 'S115', 'journal-title': 'J Anaesthesiol Clin Pharmacol', 'key': 'ref47', 'volume': '38', 'year': '2022'}, { 'DOI': '10.1111/ane.13471', 'author': 'Xiong', 'doi-asserted-by': 'publisher', 'first-page': '251', 'journal-title': 'Acta Neurol Scand', 'key': 'ref48', 'volume': '144', 'year': '2021'}, { 'key': 'ref49', 'unstructured': 'SpringerLink. Disorders of consciousness in hospitalized patients with ' 'covid-19: the role of the systemic inflammatory response syndrome. ' 'Available from: ' ' Accessed ' 'November 2, 2022.'}, { 'key': 'ref50', 'unstructured': 'SpringerLink. Altered mental status in COVID-19. Available from: ' ' Accessed ' 'November 2, 2022.'}, { 'DOI': '10.5005/jp-journals-10071-23592', 'author': 'Gupta', 'doi-asserted-by': 'publisher', 'first-page': '975', 'journal-title': 'Indian J Crit Care Med', 'key': 'ref51', 'volume': '24', 'year': '2020'}], 'reference-count': 51, 'references-count': 51, 'relation': {}, 'resource': { 'primary': { 'URL': ''}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': ['Pharmacology (medical)', 'Infectious Diseases', 'Pharmacology'], 'subtitle': [], 'title': 'Thirty-Day Outcomes of Young and Middle-Aged Adults Admitted with Severe COVID-19 in Uganda: A ' 'Retrospective Cohort Study', 'type': 'journal-article', 'volume': 'Volume 16'}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop